Coreline Soft Expands AI Lung Cancer Screening Infrastructure Across Germany’s Public Healthcare Network

- Coreline Soft supplies its AI-based thoracic disease analysis platform to the public teaching hospital Klinikum Chemnitz in Germany.
- From national pilot to regional network: transforming the lung cancer screening ecosystem.

Seoul, Korea – October 23, 2025 – Coreline Soft announced that it has deployed its AI-powered thoracic disease diagnostic platform, AVIEW LCS Plus, at Klinikum Chemnitz GmbH, a major public hospital in Saxony, Germany.
Klinikum Chemnitz is a public general hospital with approximately 1,785 beds and serves as a teaching hospital of TU Dresden. As one of the key medical and educational institutions in the region, it plays a central role in providing care and training in southern Saxony.
This latest deployment demonstrates how the clinical trust and operational references Coreline Soft has built through Germany’s national lung cancer screening pilot project HANSE are now expanding to regional medical networks. The adoption of AVIEW LCS Plus by public and teaching hospitals marks a shift from initial tertiary-care references toward real-world, community-level implementation.

The HANSE Project is a leading example of how AI-based lung cancer screening frameworks have been validated within Germany. Following the project, the German federal government formally recommended the use of AI reading solutions as an essential component of the national lung cancer screening process, establishing a regulatory foundation for broader adoption.
Coreline’s AVIEW LCS Plus, which played a key role in the project, is specialized in lung nodule detection and quantification and has obtained major global regulatory certifications including U.S. FDA 510(k), CE-MDR, HIPAA, and GDPR compliance.

“Across Europe, national lung cancer screening programs are gaining momentum,” said Jin Kook Kim, CEO of Coreline Soft. “AI-driven image reading software is becoming not only a tool for efficiency but a critical infrastructure that enhances accessibility and diagnostic consistency in preventive care. We’ll continue working closely with local clinicians to ensure that our AI technologies deliver real-world value to patients.”

Coreline Soft currently supplies its AVIEW software suite to six of the top 10 hospitals in Germany, including University Hospital Bonn and University Hospital Heidelberg. Germany represents the largest medical device market in Europe—accounting for approximately 25% of the region—and ranks fourth globally after the U.S., China, and Japan.